Protein A Resins Market Size is set to Grow at a Remarkable Pace in the Coming Years

As per a recent market analysis by Future Market Insights (FMI), the demand in the Protein A Resins Market is anticipated to increase at 8.1% CAGR, surpassing US$ 1.2 Bn by 2031-end.

Download a Sample Copy of report to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1720

Researches conducted on monoclonal antibodies and development of biosimilar drugs will drive the demand for protein A resins. Need for advanced and accurate biosimilars to reduce the risk of cancer across the globe is encouraging research on monoclonal antibodies.

As per FMI, demand for protein A resins is increasing in contract manufacturing organizations (CMO). Favorable research initiatives and funding in CMOs for the manufacturing of monoclonal antibodies will provide impetus to the growth in the market.

The outbreak of COVID-19 accelerated the sales of protein A resins as development of monoclonal antibodies for the treatment of virus increased. Apart from this, demand for natural protein A resins in the purification of monoclonal antibodies burgeoned during the FQ-20.

As natural protein A resins help in minimizing ligand leaching and provide stability to traditional protein A resins, key players are increasing the adoption to for advanced research purposes. On the back of this, demand for natural protein A resins is expected to surge in biopharmaceutical manufacturing companies over the forecast period.

As per FMI, sales of protein A resins for antibody purification will account for maximum share during the forecast period. Rising cases of cancer and other chronic diseases have increased the need for developing monoclonal antibodies for therapeutic uses.

Hence, biopharmaceutical manufacturing companies are actively seeking strategic partnerships and mergers with other key players to launch new products, therapeutic drugs, and gain competitive edge in the industry.

“Steered by increasing demand for biosimilar and monoclonal antibodies for therapeutic use, biopharmaceutical manufacturing companies are increasing investments in research and development activities to push biologics production. This is expected to create lucrative growth opportunities for market players,” says an FMI analyst.

Ask from the Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1720

Key Takeaways:

  • The U.S. is expected to dominate the North America’s protein A resins market, holding over 93.5% market share
  • The U.K. will account for nearly 24.1% of market share across Europe due to increasing number of biopharmaceutical companies focusing on development of biosimilar drugs
  • China is expected to register growth at 9.8% CAGR in East Asia owing to the increasing use of biomaterials in drug research
  • Sales of protein A resins across Japan are expected to increase at 7.8% CAGR during the forecast period
  • Based on matrix type, agarose based matrix of protein A resins will account for over 85.8% market share in 2021
  • Biopharmaceutical manufacturers are expected to be the primary end-users, accounting for 79.2% market share in 2021

Prominent Drivers:

  • Growing demand for therapeutic antibodies and extensive research on monoclonal antibodies will boost the market
  • Increasing prevalence of cancer has encouraged medical professionals for extensive research on the production of monoclonal antibodies for therapeutic use. This is propelling the demand in the market

Key Restraints:

  • High cost of resins and lack of skilled research analysts are expected to restrict the growth in protein A resins market

Request for Customized Report – https://www.futuremarketinsights.com/customization-available/rep-gb-1720

Competitive Landscape

Key players are collaborating with end users and other regional players to strengthen their global presence. Some of the market players are focusing on product launches to capitalize on growing demand for monoclonal antibodies from biopharmaceutical companies. For instance:

  • In Spetember 2021, Purolite, a global manufacturer of resin-based chromatography separation, purification, and extraction technologies, announced the commercialization of two novel next-generation chromatography resins.
  • In March 2020, Avantor Inc., global provider of mission-critical products and services to customers in the life-sciences, announced a new recombinant Protein A affinity chromatography resin, PROchievA, used to purify antibodies during mAbs production.

Leading players operating in protein A resins market profiled by FMI include:

  • GE Healthcare
  • Thermo Fisher Scientific
  • Kaneka Corporation,
  • JNC Corporation
  • Purolite Life Sciences
  • Bio-Rad Laboratories, Inc.
  • JSR Corporation (JSR Life Sciences LLC)
  • Repligen
  • Tosoh Bioscience, Merck Group (Merck Millipore)
  • Novasep Holdings SAS, Agilent Technologies, Inc.
  • GenScript, Abcam PLC (Expedeon Ltd.)
  • Avantor Inc.
  • Takara Bio, PerkinElmer, Inc.
  • Suzhou Nanomicro Technology Co., Ltd
  • Others

Buy Now@ https://www.futuremarketinsights.com/checkout/1720

More Insights on FMI’s Protein A Resins Market

The latest market study on the protein A resins market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to offer a better perspective of the global protein A resins market, its growth trajectory, trends, and opportunities, the market is segmented on the basis of:

By Product:

  • Natural Protein A Resin
  • Recombinant Protein A Resin

By Matrix:

  • Agarose Based Matrix
  • Glass or Silica Based Matrix
  • Organic Polymer Based Matrix

By Application:

  • Immunoprecipitation
  • Antibody Purification

By End-User:

  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes

Key Questions Covered in Protein A Resins Market Report 

  • The report offers detailed insights into protein A resins market demand outlook for 2021-2031.
  • The market study also highlights projected sales growth for protein A resins market between 2021 and 2031.
  • Protein A resins market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry.
  • Protein A resins market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Dental Imaging Equipment Market | Global Analysis and Opportunity Assessment 2022-2030

Future Market Insights’ recently published report on the Dental Imaging Equipment Market predicts that growth is expected to accelerate at a positive 7.9% CAGR during the forecast period of 2022-2030.

Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/sample/rep-gb-861

The COVID-19 pandemic has reduced the number of patients with dental problems visiting healthcare settings due to mandatory enforcement of social distancing measures. Moreover, healthcare providers have reoriented their operations towards caring for COVID-19 positive patients.

“Market players need to concentrate more on providing high resolution imaging in order to provide enhanced treatment. Techniques such as 3D-imaging, fluoroscopy and 4K ultra-HD will greatly augment market prospects for dental imaging equipment in the future,” opines an FMI analyst.

Key Takeaways from FMI’s Dental Imaging Equipment Market Study

  • Extraoral X-ray systems emerged as the kingpin in the dental imaging equipment market, accounting for ~30% of the revenue pie in 2019
  • The popularity of intraoral sensors is gradually increasing, with prominent manufacturers doling out various two and three dimensional image sensors
  • Independent dental clinics are the primary end-users of dental imaging equipment, capturing nearly 70% of the market share in 2019
  • Asia-Pacific shall emerge as the fastest growing dental imaging equipment market followed by Africa and Latin America

Dental Imaging Equipment Market- Key Trends

  • Cone Beam Computed Tomography (CBCT) imaging is emerging as the gold standard for dental imaging. These systems are being leveraged to provide 3-dimensional data at a lower radiation dose and cost
  • Market players are investing in cutting-edge image-guided implant dentistry with lightning fast speeds to provide efficient treatment within a limited timespan
  • However, inadequate insurance coverage for dental treatment combined with its expensive nature is expected to deter patients from availing image-based dental care, impeding growth prospects

Inquire Before Buying Research Report: https://www.futuremarketinsights.com/ask-question/rep-gb-861

Dental Imaging Equipment Market- Region-wise Analysis

  • North America and Europe shall remain the dominant dental imaging equipment market growth avenues. Increasing awareness among patients about sophisticated image based surgeries is prompting dental clinics to adopt high-end dental imaging equipment
  • Exponentially increasing population pools in countries such as China and India are leading to increased prevalence of dental diseases. With the levels of disposable incomes rising due to economic growth, patients can afford expensive dental treatment, pushing up dental imaging equipment adoption in healthcare settings across Asia-Pacific
  • Rising dental care awareness in Brazil and South Africa is pushing up sales of dental imaging equipment in both regions

Dental Imaging Equipment Market- Competitive Landscape

The dental imaging equipment market players are concentration on incorporating artificial intelligence and provide state-of-the-art imaging equipment to the end-users, thus providing them with a comparative advantage. For instance, in October 2019, DENTSPY Sirona Inc. launched the Xios AE and Xios XG Supreme intraoral scanners, providing outstanding image quality. These systems provide a theoretical resolution of 33 lp/mm and a 15 micrometer pixel size.

Another strategy which is actively followed is venture capital funding to facilitate research and development on advanced dental imaging equipment.

In February 2018, Nordic capital forged agreements with Adent Cliniques Dentaires Groupe SA to acquire TopOrtho and Top Mondzorg Dental Clinics for the purpose of furthering dental imaging research.

Similarly, the Asian Healthcare Fund invests in the Indian healthcare and life sciences sector and includes the investment programs titled “MyDentist” and “Sabka Dentist” since the past decade.

Buy Now@ https://www.futuremarketinsights.com/checkout/861

More Valuable Insights on Dental Imaging Equipment Market

Future Market Insights provides an unbiased insight on the dental imaging equipment market forecasted for the period 2020-2030. It delves into the analysis on revenue growth at global, regional, and country levels and the latest industry trends in each of the segments. The global dental imaging equipment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights by bringing to the fore insights helping stakeholders identify opportunities as well as challenges.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

General Anesthesia Drugs Market Growth, Regional Analysis, Trends and Forecast 2022-2032

The General Anesthesia Drugs Market is expected to be adversely impacted by the coronavirus outbreak. The pandemic has largely suspended anesthetic medical procedures, of a non-urgent nature, substantially reducing demand for general anesthesia drugs in the short term. Closure of clinics in nationwide lockdowns, and postponed elective medical procedures in the near future will hamper the general anesthesia drugs market. Recovery of the industry is dependent on the severity and duration of the disease.

Request a sample of the report to gain in-depth market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-388

“Tech advancements in drug delivery apparatus, research on patient monitoring devices, and targeted drugs for patients during and after the use of anesthesia, and reduction of side effects from modern anesthetic drugs are providing impetus to growth of the general anesthesia drugs market,” says the FMI analyst.

General Anesthesia Drugs Market – Key Takeaways

  • Propofol is a highly popular general anesthesia drug, aided by low risk of side effects.
  • Injectables remain the common general anesthesia drug delivery method, owing to superior efficacy properties.
  • Asia Pacific is a leading market for general anesthesia drugs, owing to rising demand for surgical intervention in chronic diseases such as diabetes.

General Anesthesia Drugs Market – Key Driving Factors

  • Rising cases of cardiovascular diseases is a key factor supporting the sales of general anesthesia drugs.
  • A rapidly ageing population with a wide range of chronic ailments generates demand for general anesthesia drugs.
  • Investments into research for drug delivery methods and drug formulations support market growth.

General Anesthesia Drugs Market – Key Constraints

  • Lack of standardization in terms of anesthesia management techniques hinders market developments.
  • High cost of branded anesthetics and associated medical procedures holds back market growth.

Explore the global general anesthesia drugs market report with 75 illustrative figures, 41 data tables and the table of contents. You can also find a comprehensive market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-388

The Anticipated Impact of Coronavirus

Anesthetic practices have been substantially impacted by the coronavirus pandemic. Numerous clinics have had to suspend their operations, as elective medical procedures have been directed to be postponed. On the other hand, surgical interventions for aged covid-19 patients will generate opportunities, which will partially mitigate losses incurred during this crisis period.

Competition Landscape

Players in the general anesthesia drugs market include but are not limited to Abbott Laboratories, AbbVie Inc., Astra Zeneca Plc, Baxter International Inc., and Fresenius SE & C. KGaA. Developers are investing in investing in research for product development, and wider scope of application. For instance, sevoflurane has been found to improve outcomes of patients with sepsis.

More About the Report

The FMI’s market research report offers detailed insights on general anesthesia drug s market. The market is scrutinized on the basis of drug class (propofol, sevoflurane, dexmedetomidine, desflurane, remifentanil, midazolam, and others), route of administration (intravenous anesthesia, and inhaled anesthesia), and end user (hospitals, ambulatory surgical centers, and specialty clinics) across seven key regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa).

Buy Now Complete Report@ https://www.futuremarketinsights.com/checkout/388

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Continuous Glucose Monitoring System Market Projected to Gain Significant Value through 2022-2032

According to a recent market report published by Future Market Insights, titled “Continuous Glucose Monitoring Systems Market – Global Industry Analysis and Opportunity Assessment, 2015–2020”, the global continuous glucose monitoring systems market was valued at US$ 445.8 Mn in 2015 and is expected to register a CAGR of 12.1% from 2015 to 2020.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-694

Continuous glucose monitoring systems are adopted by many end-users including household, and hospitals and diagnostics centers. There is an increase in the usage of continuous glucose monitoring systems components in hospitals and diagnostic centers due to an increase in the demand for sensor.

Currently, companies are focusing on continuous development and the introduction of innovative continuous glucose monitoring system devices to receive FDA approval for various brands, which has led to high competitiveness in the market. Scientists are conducting research and testing continuous glucose monitoring systems to provide effective systems and aid better management of diabetes.  Thus, there is scope for the introduction of new and advanced continuous glucose monitoring systems in the near future. Market players operating in the continuous glucose monitoring systems market are focused towards the integration of advanced technologies in products in order to offer variations and trends in the type of blood glucose level display.

On the other hand, the high cost of continuous glucose monitoring systems acts as a restrain for the growth of the market as treatment with continuous glucose monitoring systems costs around US$ 4,930 to US$ 7,120 per person. This makes it unaffordable for a large portion of the global population. For instance, glucose monitors used in continuous glucose monitoring systems cost between US$ 1,000 and US$ 1,400, while sensors cost between US$ 35 and US$ 100 apiece. Besides this, sensors have a very short lifespan – around 3 to 7 days – since they are prone to biofouling, which affects the accuracy of the continuous glucose monitoring systems.

Due to the lack of accuracy in the readings of glucose levels in critical cases, continuous glucose monitors are incapable of preventing severe hypoglycemia stage, in which the glucose level in the body is extremely low. For instance, continuous glucose monitoring systems are up to 21% less accurate when compared with actual plasma glucose values and this percentage increases when there is a rapid rise and fall in plasma glucose. According to the results of studies, it is estimated that the probable reason behind this problem is the real-time performance delay of continuous glucose monitoring systems.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-694

The global continuous glucose monitoring systems market has been categorized on the basis of component into transmitter & monitor, sensor and insulin pump. On the basis of end-use, the continuous glucose monitoring systems market has segmented into household and hospitals and diagnostics centers. In terms of revenue, the household segment dominated the global continuous glucose monitoring systems market. Hospital and diagnostics centers segments are anticipated to expand at the fastest CAGRs over the forecast period.

This continuous glucose monitoring systems report also covers trends that drive each segment and offers analysis & insights regarding the potential of the continuous glucose monitoring systems market in regions such as North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East & Africa, and Japan. Among these regions, the APEJ continuous glucose monitoring systems market is projected to exhibit relatively high growth in the global continuous glucose monitoring systems market with a CAGR of 16% over the forecast period. Revenue from the continuous glucose monitoring systems market in APEJ accounted for over 7% of the global continuous glucose monitoring systems market revenue in 2015. Providers of continuous glucose monitoring systems can focus on expanding across several countries in APEJ such as India and China.

Some of the key competitors in the continuous glucose monitoring systems market include Abbott, Medtronic, Dexcom, Animas, Roche, Bayer, Glysens and Ypsomed. These key players are constantly focusing on product innovation and geographical expansion to sustain their market presence and increase revenue generation by developing various types of devices and delivering outstanding offerings to several end-users.

Rising Prevalence of Diabetes and Integration of Artificial Pancreas Systems in continuous Glucose monitoring systems market

The increasing prevalence of diabetes worldwide is driving the demand for innovative and effective diabetic management devices such as continuous glucose monitoring systems. For instance, as per the International Diabetes Federation, 285 Million people worldwide suffered from diabetes in 2012; out of these, the U.S. accounted for approximately 18.8 Million cases. These facts indicate that the U.S. has high prevalence of diabetes and thus, has high market potential for continuous glucose monitoring systems.

Artificial pancreas device systems are effective in the management of diabetes. In artificial pancreas systems, continuous glucose monitoring systems technology is combined with insulin pumps in order to administer optimum dosage to manage blood-glucose levels. This will increase the demand for continuous glucose monitoring systems in the market.

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/694

Key Segments Covered in the continuous glucose monitoring system Market

Component

  • Transmitter & monitor
  • Sensor
  • Insulin Pump

End-user

  • Household, and hospitals
  • Diagnostics Centres

Key Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Japan
  • APEJ
  • Middle East & Africa

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

High Content Screening Market expected to See Incredible Growth by 2031 | FMI

This Future Market Insights report examines the ‘High Content Screening (HCS) Market‘ for the period 2015–2025. New product launches are resulting in product assortment and thus, increased installation of High Content Screening (HCS) instruments. This is expected to bolster growth of the High Content Screening (HCS) market over the next five to six years. Furthermore, increasing government support for research and development for drug discovery processes across the globe is expected to drive the growth of High Content Screening (HCS) market during the forecast period. Companies are focussing on penetrating untapped markets, such as Asia Pacific and Latin America, where growth of the biotechnology and biopharmaceutical industry is expected to increase significantly.

To get the sample copy of report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-426

The High Content Screening (HCS) market report starts with an overview of cell analysis instrumentation market. In addition, this section includes FMI’s analysis of the key trends, drivers and restraints from the supply, demand and economy side, which are influencing the High Content Screening (HCS) market. Impact analysis of key growth drivers and restraints, based on the weighted average model is included in the High Content Screening (HCS) Market report to better equip and arm clients with crystal clear decision-making insights.

The global High Content Screening (HCS) market is segmented on the basis of product, application, industry and regions. On the basis of product, the market is segmented as cell imaging and analysis equipment, consumables, software and services. Cell imaging and analysis equipment is further sub-segmented as High Content Screening (HCS) instruments and flow cytometers. Also, High Content Screening (HCS) instruments are categorised into high-end High Content Screening (HCS), mid-end High Content Screening(HCS) and low-end High Content Screening (HCS) instruments. A detailed analysis has been provided for every segment in terms of market size and volume analysis for High Content Screening (HCS) instruments across the globe.

In the next section, FMI covers the High Content Screening (HCS) market performance in terms of application. On the basis of application, the High Content Screening (HCS) market is segmented into primary and secondary screening, target identification and validation, toxicity studies, compound profiling and others. A detailed analysis has been provided for every segment in terms of market size.

Also, FMI provides the High Content Screening (HCS) market analysis of end-use sectors for High Content Screening (HCS). The segmentation includes pharmaceutical and healthcare, biotechnology companies, educational institutions, government organisations and others. A detailed analysis has been provided for every segment in terms of market size.

As highlighted earlier, the High Content Screening (HCS) market is segmented on the basis of product, application, industry and regions. All these segments are included in this section to make the study more comprehensive. The subsequent sections provide detailed analysis on the product type, industry and application of the High Content Screening (HCS) market report. The sections provide detailed analysis covering key trends, absolute dollar opportunity and BPS Analysis.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-426

The next section of the report highlights High Content Screening (HCS) adoption by regions. It provides market outlook for 2015–2025 and sets the forecast within the context of the High Content Screening (HCS) ecosystem, including the new technological developments as well as product offerings in the High Content Screening (HCS) market. This study discusses the key region trends contributing to growth of the High Content Screening (HCS) market globally, as well as analyses the degree at which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East and Africa.

All the above sections, by product, by application, by industry or by regions, evaluate the present scenario and the growth prospects of the High Content Screening (HCS) market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the trailing 12 months.

To calculate the High Content Screening (HCS) market size, we have considered revenue generated by the High Content Screening (HCS) manufacturers. The forecast presented here assesses the total revenue by value across the High Content Screening (HCS) market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the High Content Screening (HCS) market will develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities across the High Content Screening (HCS) market.

As previously highlighted, the High Content Screening (HCS) market is split into a number of segments and sub-segments. All the High Content Screening (HCS) segments in terms of product type, application, industry and regions are analysed in terms of Basis Point Share to understand individual segment’s relative contributions to market growth. This detailed level of information is important for the identification of various key trends of the High Content Screening (HCS) market.

Also, another key feature of this report is the analysis of all key segments and sub-segments in terms of absolute dollar. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the High Content Screening (HCS) market.

Furthermore, to understand key growth segments in terms of growth & adoption of high content screening for cell analysis along with preferred application across the globe in the near future, Future Market Insights developed the High Content Screening (HCS) Market Attractiveness Index. The resulting index should help providers identify real market opportunities.

Buy Now@ https://www.futuremarketinsights.com/checkout/426

In the final section of the report, High Content Screening (HCS) Competitive landscape is included to provide report audiences with a Dashboard view, based on categories of provider in the value chain, presence in High Content Screening (HCS) product portfolio and key differentiators. Key categories of providers covered in the report are High Content Screening (HCS) manufacturers. This section is primarily designed to provide clients with an objective & detailed comparative assessment of key providers specific to a market segment in the High Content Screening (HCS) value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and success in High Content Screening (HCS) marketplace. Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the High Content Screening (HCS) space. Key competitors covered in terms of manufacturers are Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex Corporation and Thorlabs Inc.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Real Time Continuous Microbiological Monitoring Systems Market Key Indicators, Forecast and COVID 19 Impact Analysis 2028

Pharmaceutical and biotechnology companies who produce medicine and biotech products are concern about airborne microbial contamination. Traditionally, these companies use active air samplers or settling plate method to detect the airborne microbial contamination.

But, this method may require at least four to ten days to detect the microbial contamination in the lab. Real time continuous microbiological monitoring systems is emerging tool used by pharmaceutical and biotechnology companies to detect the airborne microbial contamination.

Real time continuous microbiological monitoring systems is based on Laser Induced Fluorescence (LIF) technology to detect the airborne microbial contamination. This system offers real-time detection of active biological organisms which used for the produce of sterile products.

Real time continuous microbiological monitoring systems are designed with stainless steel and it is enclosed with sample probe. This sensor is directly connected to a software and it is designed to attain the continuous operation.

As the air passes through the system detect the biological particle by laser illumination. These air particles are counted by laser illumination depending upon their size and it is displayed on the monitor.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-6945

Real Time Continuous Microbiological Monitoring Systems Market: Drivers and Restraints

Increasing research and development by the pharmaceutical and biotechnology to develop advance medicine and biotech product is the primary factor driving the growth of real time continuous microbiological monitoring systems market.

The waiting time for the result by traditional method is four to ten days whereas this system provide real time data for active microbial contamination which is also gaining the traction for real time continuous microbiological monitoring systems. This system reduces the operator error and do not require any paper data management, moreover it easy to operate this system and does not require any special handling, training, or logistics which lead to increase demand of real time continuous microbiological monitoring systems in the global market.

Real time continuous microbiological monitoring system is costly equipment, therefore research lab which has less funding could not afford this latest technology which may deter the growth of this market throughout the forecast period.

Real Time Continuous Microbiological Monitoring Systems Market: Overview

The global real time continuous microbiological monitoring systems is expected to show significant growth over the forecast period due to rising research and development by the pharmaceutical and biotechnology to develop advance medicine and biotech product.

The leading player of real time continuous microbiological monitoring systems emphasis on continuous product launches though this system is gaining huge traction in the market. But the adoption of this system in the institutional laboratory is quite low while it is mostly used in research and development laboratory.

The major application of real time continuous microbiological monitoring systems is in drug discovery and clinical research, therefore these segment is estimated to dominate the market by application.

Among all end user, real time continuous microbiological monitoring systems are mostly used in biopharmaceutical companies, hence this segment is estimated gain more incremental opportunity over the forecast period.

Real Time Continuous Microbiological Monitoring Systems Market: Regional Overview

On the basis of regional presence global real time continuous microbiological monitoring systems are classified into eight key regions – North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China & Japan, China, Japan, and the Middle East & Africa.

North America is the most lucrative market for real time continuous microbiological monitoring systems due to increasing research and development in life sciences industries.

After North America, real time continuous microbiological monitoring systems market is then followed by Western Europe and Japan. In APECJ region, India and Australia are the major markets for real time continuous microbiological monitoring systems due rising number of pharmaceutical industries in these countries.

The MEA and Latin America is expected to show relatively low adoption real time continuous microbiological monitoring systems owing to less funding for biopharmaceutical research and development.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-6945

Real Time Continuous Microbiological Monitoring Systems Market: Key Players

Examples of some of the market participants in real time continuous microbiological monitoring systems market identified across the value chain include Alpha Controls & Instrumentation Inc. Mettler Toledo, BioVigilant, MicronView LLC and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-6945

Real Time Continuous Microbiological Monitoring Systems Market: Segmentation

The global real time continuous microbiological monitoring systems market is classified on the basis of application, end user, and region.

Based on application real time continuous microbiological monitoring systems market is segmented into following:

  • Drug Discovery & Development
  • Clinical Research
  • Biopharmaceutical Production
  • Drug Screening
  • Tissue Engineering
  • Others

Based on end user Real Time Continuous Microbiological Monitoring Systems market is segmented into following:

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Food & Beverage Companies
  • Others

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Gastrointestinal Stent Market Size to Reach USD 600 Mn by 2026 | FMI

As per the gastrointestinal stent market survey by Future Market Insights (FMI), the market is poised to attain a CAGR of 6% during the forecast period, i.e., 2022-2032.

The rising preference for minimally invasive (MI) surgical procedures is having a significant impact on the gastrointestinal stent market growth as in comparison to traditional open surgery procedures; stenting has a lower risk of gastrointestinal infection, less blood loss, and a shorter recovery period.

As per gastrointestinal stents market study, gastrointestinal stents market future trends are likely to be swayed by various technological advancements, such as the development of gastrointestinal biodegradable stents and nitinol material-based stents with a high degree of flexibility and kink-resistance can be considered as some of the major emerging trends in gastrointestinal stent market.

Ongoing research and development activities in the business sector are also expected to sway the gastrointestinal stents adoption trends during the forecast period. For example, Brigham and Women’s Hospital and MIT researchers announced the development of a stretchable stent with pop-out needles for use in drug delivery in gastrointestinal systems and other tubular organs.

Sales of gastrointestinal stents are likely to surge owing to significant growth in healthcare infrastructure, favorable government policies, and extensive research and development (R&D) activities.

In most Asian countries, government reimbursement for endoscopic stenting procedures is limited or non-existent, one of the major reasons for patient and physician reluctance to use gastrointestinal stents, narrowing down the gastrointestinal stents market outlook.

Such a high cost and a lack of reimbursement in developing countries such as India are expected to limit patient adoption of gastrointestinal stent-related procedures.

Taking into account the factors mentioned above, the gastrointestinal market size is projected to reach US$ 600 Mn by 2026.

Key Takeaways:

  • Due to the increasing prevalence of chronic liver disease and the increase in the number of surgical procedures for the treatment of biliary diseases, the biliary stents segment is likely to account for the largest gastrointestinal stents market share as per the product type.
  • Based on material, self-expanding metal stents are expected to lead the market. The same can be credited to benefits such as ease of insertion, a lower possibility of dislodgment or migration, and longer patency.
  • During the forecast period, the gastrointestinal cancers segment is anticipated to have the highest CAGR attributed to the increased prevalence and incidence, thereby positively impacting the gastrointestinal stents market trends.
  • The hospitals and clinics segment will be at the forefront of the market, owing to many endoscopic retrograde cholangiopancreatographies (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures performed in hospitals for various disease indications.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14295

“In terms of market share and revenue, North America is predicted to dominate the gastrointestinal/GI stent market and will maintain its dominance throughout the forecast period on account of a sophisticated level of healthcare facilities, a rising geriatric population, high incidence of gastrointestinal diseases, favorable reimbursement scenario, and presence of key market players such as C.R. Bard (US), and Becton, Boston Scientific Corporation (US), Dickinson and Company.” opines an FMI researcher.

Competitive Landscape:Among the prominent players in the GI, stents market are Merit Medical Systems (US), Cantel Medical (US), Olympus Corporation (Japan), CONMED Corporation (US), Taewoong Medical (South Korea), Endo-Flex GmbH (Germany), Micro-Tech (Nanjing) Co., Ltd. (China), MI-Tech (South Korea), QualiMed (Germany), UK Medical (UK), Hobbs Medical Inc. (US), CITEC (China), BCM Corporation (South Korea), Leufen Medical GmbH (Germany) and Medorah Meditek Pvt. Ltd. (India).

The gastrointestinal stent market is moderately competitive, with numerous gastrointestinal stents market opportunities. In addition, the increasing prevalence of diseases associated with gastrointestinal tract stent placement is driving up demand for gastrointestinal stents.

As a result, several global corporations are implementing various strategies to reach out to emerging economies such as product launches, mergers, acquisitions, partnerships, collaborations, etc.

Some of the recent developments in the gastrointestinal stents market are:

  • Cook Medical worked with Taewoong Medical to expand patient treatment options by distributing a variety of Taewoong’s stents in the United States. The Niti-STM Through the Scope (TTS) Esophageal Stent, the flagship product of the South Korean company’s Niti-S Self-Expandable line of the metal gastrointestinal stent, is included in this distribution collaboration.
  • Olympus has proposed a couple of self-expanding metal stents (SEMS) to be used as palliative measures in patients with a short life expectancy or who have malignant colonic or duodenal obstruction.

Key Segments

By Product:

  • Biliary Stents
  • Duodenal Stents
  • Colonic Stents
  • Pancreatic Stents
  • Esophageal Stents

By Material:

  • Self-Expanding Metal Stents
  • Plastic Stents

By Application:

  • Biliary Diseases
  • Irritable Bowel Syndrome
  • Gastrointestinal Cancers
  • Colorectal Cancer
  • Stomach Cancer
  • Esophageal Cancer
  • Pancreatic Cancer

By End User:

  • Hospitals And Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14295

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage

2.2. Market Definition

  1. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Gastrointestinal Stent

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14295

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Cleanroom Technologies Market will reach a value of USD 13.29 Billion by 2032

The cleanroom technologies market study conducted by Future Market Insights is projected to expand at a CAGR of 6% to US$ 13.29 Bn by 2032, up from US$ 7 Bn in 2021. The rising demands for sterilized pharmaceutical formulations and the growing demand for medical device cleanrooms are driving this cleanroom technologies market growth.

In the subsequent years, technological advancements in cleanroom technology and rising demand for cleanroom technologies in developing economies are likely to provide significant cleanroom technologies market potential possibilities.

The study finds that cleanroom technologies market constraints associated with their operational expenses and the technical problems associated with modifying cleanroom designs in developing economies are hampering the cleanroom technologies market growth.

ISO 6 cleanrooms and ISO 8 cleanrooms have different prices per square foot. This is due to the fact that the volume of air delivered in both types of cleanrooms differs. In an ISO 6 cleanroom, the air is 100 times cleaner than in an ISO 8 cleanroom, increasing the air conditioning capacity of the HVAC systems.

The demand to maintain an antimicrobial environment by eliminating airborne particles in these facilities increases as the number of hospitals and Ambulatory Surgery Centers (ASCs) grows due to the various perks they provide.

There are no defined cleanroom design standards for various application areas or product types. This presents several difficulties for cleanroom technologies manufacturers, as they must adhere to various designs each time. There are no requirements for environmental, product, or facility factors to be controlled in the legislation. Instead, they only give requirements that a corporation must follow after manufacturing a product in a cleanroom setting.

Consumables dominated the cleanroom technology market in 2020, accounting for the most revenue. Another critical factor attributing to the segment’s highest cleanroom technology market share is the frequent usage of consumables and high sales of cleanroom consumables, notably gloves.

Due to the particular sensitivity of processes, cleanroom technology is vital for biotechnology-based operations such as research and development, biocontamination control, pilot studies, and production facilities. Consequently, demand for cleanroom technology is anticipated to grow as the biotechnology industry grows significantly over the forecast period.

According to the report, North America dominated the cleanroom technology market, accounting for most sales of cleanroom technology.

This is due to the region’s well-established healthcare infrastructure, the presence of significant pharmaceutical and medical device cleanroom businesses on the ground, an increase in the burden of non-communicable diseases, and growth in cosmeceutical and nutraceutical awareness. Moreover, restrictive laws governing the approval of healthcare items in this region, such as the United States, have boosted demand for cleanroom technology.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14283

Key Takeaways:

  • The consumables segment leads the cleanroom technology market in 2020, accounting for 54.1% of total revenue.
  • In 2020, the pharmaceutical industry segment was expected to dominate the cleanroom technology market by end-use, accounting for 40.3% of total revenue.
  • Due to the increased acceptance of biotechnology commodities worldwide, the biotechnology industry segment in the cleanroom technologies market is predicted to develop at the fastest rate of 7.2% over the forecast period.
  • The equipment segment held a dominant position in the cleanroom technologies market in 2019, accounting for 74.2% share in terms of value.
  • North America held the largest cleanroom technology market share in 2020, accounting for 35.5% of total revenue.

Competitive Landscape:

The cleanroom technology market is highly fragmented, with more regional competitors than cleanroom technology market manufacturers present. Mergers and acquisitions, as well as R&D relating to modular cleanroom systems’ developments, are some of the major strategies used by leading firms to grow their cleanroom technology market share.

The major cleanroom technology market manufacturers covered in the cleanroom technology market report are Simplex Isolation Systems, AES Clean Technology, DuPont, Clean Air Products, Clean Room Depot, Inc., Integrated Cleanroom Technologies Private Limited, Hemair, AIRTECH JAPAN, Ltd., Lennox International Inc., COLANDIS GMBH, ABN Cleanroom Technology, Nicos Group, Inc., Galvani S.r.l., ANSELL LTD., Ardmac, Azbil Corporation, novum. Reinraumtechnik, Helapet Ltd., KCWW, Camfil, Labconco, Taikisha Ltd, Terra Universal. Inc. and Lindner Group, among other domestic and universal cleanroom technologies market manufacturers.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14283

Key Segments

By Product Type:

  • Equipment
  • Fan Filter Unit (FFU)
  • HVAC Systems
  • Laminar Air Flow Systems and Biosafety Cabinets
  • HEPA Filters
  • Air Diffusers and Showers
  • Safety Consumables
  • Cleaning Consumables

By End User:

  • Pharmaceuticals Industry
  • Biotechnology Industry
  • Medical Device Manufacturer
  • Hospitals

By Construction Type:

  • Standard/Drywall Cleanroom
  • Hardwall Cleanroom
  • Softwall Cleanrooms
  • Terminal Boxes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14283

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Lateral Flow Assays Market is projected to grow at a rate of 2% from 2022 – 2032

According to a recent lateral flow assays market report by Future Market Insights (FMI), the lateral flow assays market was valued at US$ 11 Bn in 2021, is projected to reach US$ 12.5 Bn by 2026, and is anticipated to grow at a CAGR of around 2% over the projected period of 2022-2032.

The high rate of infectious diseases around the world, explosive growth in the geriatric population, escalating demand for point-of-care testing, and increased use of home-based rapid lateral flow devices are all boosting lateral flow assays market forward. The significant restraints are doctors’ and patients’ reluctance to change existing diagnostic techniques and the low accuracy of lateral flow assays.

The affordable cost of lateral flow assays devices and the fact that no trained personnel is required to run the tests are two factors driving up demand for lateral flow assays-based devices for COVID-19 testing. The growing adoption of kits & reagents due to innovations and benefits of lateral flow assays rapid tests over laboratory tests the high number of lateral flow assay rapid detection kits launched by healthcare companies, predominantly for lateral flow assay COVID-19 testing, are all factors contributing to the large share of the kits & reagents segment. Sandwich assays have a considerable part of the lateral flow assays market due to the growing use of sandwich assays in medical testing and the benefits of sandwich assays.

Despite the fact that lateral flow assay tests are simple to implement and less affordable than laboratory testing, they are less reliable. Due to the apparently limited accuracy of the lateral flow assay kit, most doctors and patients prefer molecular studies to fast tests for more accurate COVID-19 diagnosis. As a result, major diagnostic lateral flow assays market participants are concentrating their efforts on developing more laboratory-based infectious disease testing solutions.

Infectious disease lateral flow assays diagnostics, cardiac disease diagnosis, and veterinary applications are typical applications for lateral flow tests. However, the use of lateral flow technology has grown in various new applications in recent years. Potential applications for lateral flow tests include saliva diagnostics, behavioural health, agriculture (crop quality testing), biowarfare (anthrax detection), environmental testing, and food microbiology. Lateral flow assay (immunochromatography tests/lateral flow immunoassays) technologies continue to dominate the point of care diagnostic market through 2024. The acquisition and validation of vital reagents are one of the most challenging elements of producing lateral flow assay tests. Antibodies used in assays must be evaluated for accuracy, specificity, stability, and reproducibility, as any reagent flaws can cause the lateral flow assay to fail. Another obstacle is lateral flow assays diagnostics after an antibody or antibody pair has been found.

Key Takeaways

  • The Kits & Reagents segment is anticipated to grow at a rapid CAGR of 5.3% during the forecast period.
  • The clinical testing segment accounted for 90.9% of the lateral flow tests market.
  • With a lateral flow tests market share of 70.9% in 2020, sandwich assays dominated the lateral flow tests market.
  • Blood samples were the most preferred, with a 53.1% lateral flow tests market share.
  • The hospitals and clinics segment was the most favoured, with a lateral flow tests market share of 37.6%.
  • China, the world’s second-largest economy, is expected to reach a lateral flow tests market size of US$917 million in 2027, with an annual growth rate of 8.8%.
  • Within Europe, Germany is expected to show a lateral flow tests market growth at a 4.8% compound annual growth rate (CAGR), while the rest of the European market will reach US$917 million by 2027.
  • The Asia Pacific region is expected to increase at a CAGR of 4.2% during the forecast period.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14271

Competitive Landscape

Some companies have increased their lateral flow tests market share through various strategies such as mergers and acquisitions. In contrast, others invent new diagnostic market test methods and provide innovative goods to maintain their market share.

Key Segments

By Application:

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environmental Testing
  • Drug Development & Quality Testing

By Technique:

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Sample Type:

  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Others
  • By Type
  • Kits & Reagents
  • Lateral Flow Readers

By End User:

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Pharmaceuticals & Biotechnology Companies
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14271

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

  1. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Lateral Flow Assays Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14271

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Drug Discovery Services Market Size to be worth USD 50.9 Bn by 2032 | FMI

The global demand for drug discovery services market is expected to rise at a 14.5% CAGR to acquire a valuation of US$ 50.9 Bn by the end of forecast period 2022-2032. The global drug discovery services market size was valued at US$ 15.5 Bn in 2021 and is projected to reach a valuation of US$ 32 Bn by 2026

The global drug research services industry is booming as a result of increased funding for research and innovation in a multitude of segments. The drug discovery process is a significant part of the pharmaceutical sector. The study on drug discovery services market finds that the efforts of researchers towards the development of new drug prototypes have popularized outsourcing of drug discovery services. Moreover, growing spending on research and the development of novel medications for the treatment of deadly diseases and disorders has stimulated the demand for drug discovery platform. Pharmaceutical and biopharmaceutical businesses are opting for seamlessly engaged and multifunctional solution providers for drug discovery research, from the developing phase to the late testing stages. Emerging trends in drug discovery services market portends that pharmaceutical companies opt for outsourcing as a key choice to offset the shortage of in-house manpower required for new product development, as pharmaceutical businesses face great pressure to reduce overhead costs.

Restrictive laws regulating drug research and animal testing are projected to limit drug distribution to some extent. Drug discovery service organizations are facing restrictions due to a limitation of trained employees. The use of animals in pharmaceutical research is governed by strict laws. Mice, rats, fish, amphibians, and reptiles are the most common animals utilized in scientific studies. Considerations over the ethical use of animal experimentation have prompted countries to enact animal safety and use statutes, which raises a number of impediments to the future of drug discovery services market.

The drug discovery trends indicate that Biologics, such as proteins, peptides, and monoclonal antibodies, account for more than half of the therapeutic possibilities in the initial cycle. In 2022, biologics are estimated to make up for approximately half of the income earned by the top 100 pharmaceutical drugs. As per the global market study on drug discovery services, they provide the drug discovery services market with highest growth potential through the forecast period.

Despite the fact that small-molecule pharmaceutical companies monopolize the global pharmaceutical market, players working with biologics, biosimilars, and large-molecule drugs are tapping into the drug discovery services market opportunities primarily to introduce new biologic-based treatments and rising revenue from current biologics.

All-in-all, the drug discovery services market is expected to reach a valuation of US$ 32 Bn by 2026.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14258

Key Takeaways

  • The drug discovery services market is divided into two types–chemistry and biology services. In 2020, the chemistry drug discovery services category held the greatest proportion of the market.
  • Small molecules are expected to occupy the largest share of revenue when compared to biologics. Drug discovery statistics specify that small molecules are expected to generate more than US$ 10,800 million in revenue by the end of 2026.
  • The oncology category is predicted to have the leading position, owing to the increasing number of cancer patients around the world.
  • In comparison to other innovative drug discovery services, Hit-To-Lead identification is expected to acquire the most traction.
  • As the most revenue generating phase, several CROs are already delivering Hit-to-lead identification services to pharmaceutical corporations.

“The Asia Pacific drug discovery services market growth is anticipated to be the highest during the projected duration, owing to expansions happening in the pharmaceutical and biopharmaceutical industry. A high proportion of contract research organizations (CROs), government incentives, high research and development in pharmaceutical industry, and the involvement of less restrictive standards for drug discovery programs (particularly in terms of using animals for research) across several APAC countries are some drivers sustaining the healthy growth of the drug discovery services market.”, opines a seasoned FMI analyst.

Competitive Landscape

The COVID-19 pandemic highlighted the importance of outsourcing drug discovery services for companies and research groups in North America. These companies are now working together with the government to facilitate the drug discovery process.

  • Existencia, a business using artificial intelligence in drug discovery, announced a collaboration with Diamond Light Source and Scripps Research on March 31, 2020, to identify COVID-19 antiviral treatments.
  • Samsung Biologics, a South Korean pharmaceutical business, has signed a long-term partnership with Eli Lilly and Company to develop bamlanivimab, an investigational COVID-19 virus-neutralizing antibody.

Genesis Therapeutics and Genentech announced a multi-target drug discovery AI partnership in November 2020. Genesis’ graph machine learning and drug discovery skills will be used in this cooperation to identify novel drug candidates for therapeutic targets in a variety of illness domains.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14258

Key Segment

By Process:

  • Target Selection
  • Target Validation
  • Hit-to-Lead Identification
  • Lead Optimization
  • Candidate Validation

By Type:

  • Chemistry Services
  • Biology Services

By Drug Type:

  • Small Molecules Drugs
  • Biologics Drugs

By Therapeutic Area:

  • Neurology
  • Infectious and Immune System Diseases
  • Digestive System Diseases
  • Oncology
  • Other Therapeutic Area

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Manufacturing
  • Other End Users

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14258

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs